KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis

被引：0
|
作者：
Tanja Limberger
Michaela Schlederer
Karolina Trachtová
Ines Garces de los Fayos Alonso
Jiaye Yang
Sandra Högler
Christina Sternberg
Vojtech Bystry
Jan Oppelt
Boris Tichý
Margit Schmeidl
Petra Kodajova
Anton Jäger
Heidi A. Neubauer
Monika Oberhuber
Belinda S. Schmalzbauer
Sarka Pospisilova
Helmut Dolznig
Wolfgang Wadsak
Zoran Culig
Suzanne D. Turner
Gerda Egger
Sabine Lagger
Lukas Kenner
机构：
[1] Medical University of Vienna,Division of Experimental and Translational Pathology, Department of Pathology
[2] CBmed-Center for Biomarker Research in Medicine GmbH,Division of Nuclear Medicine, Department of Biomedical Imaging and Image
[3] Central European Institute of Technology,Guided Therapy
[4] Masaryk University,Unit of Laboratory Animal Pathology
[5] Christian Doppler Laboratory for Applied Metabolomics,Institute of Biochemistry
[6] Medical University of Vienna,Institute of Animal Breeding and Genetics
[7] University of Veterinary Medicine Vienna,Institute of Pharmacology and Toxicology
[8] Christian-Albrechts-University Kiel,Institute of Medical Genetics
[9] University of Veterinary Medicine Vienna,Department of Urology
[10] University of Veterinary Medicine Vienna,Department of Pathology
[11] Medical University of Vienna,undefined
[12] Innsbruck Medical University,undefined
[13] University Cambridge,undefined
[14] CEITEC,undefined
[15] Masaryk University,undefined
[16] Ludwig Boltzmann Institute Applied Diagnostics,undefined
来源：
Molecular Cancer | / 21卷
关键词：
Prostate cancer; Senescence; Metastasis; KMT2C; MYC; p16;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] STAT3 regulated ARF expression suppresses prostate cancer metastasis (vol 6, 7736, 2015)
    Pencik, Jan
    Schlederer, Michaela
    Gruber, Wolfgang
    Unger, Christine
    Walker, Steven M.
    Chalaris, Athena
    Marie, Isabelle J.
    Hassler, Melanie R.
    Javaheri, Tahereh
    Aksoy, Osman
    Blayney, Jaine K.
    Prutsch, Nicole
    Skucha, Anna
    Herac, Merima
    Kraemer, Oliver H.
    Mazal, Peter
    Grebien, Florian
    Egger, Gerda
    Poli, Valeria
    Mikulits, Wolfgang
    Eferl, Robert
    Esterbauer, Harald
    Kennedy, Richard
    Fend, Falko
    Scharpf, Marcus
    Braun, Martin
    Perner, Sven
    Levy, David E.
    Malcolm, Tim
    Turner, Suzanne D.
    Haitel, Andrea
    Susani, Martin
    Moazzami, Ali
    Rose-John, Stefan
    Aberger, Fritz
    Merkel, Olaf
    Moriggl, Richard
    Culig, Zoran
    Dolznig, Helmut
    Kenner, Lukas
    [J]. NATURE COMMUNICATIONS, 2015, 6
  • [22] Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4
    Shidong Lv
    Liyan Ji
    Bin Chen
    Shuqiang Liu
    Chengyong Lei
    Xi Liu
    Xiaoxiao Qi
    Ying Wang
    Elaine Lai-Han Leung
    Hongyi Wang
    Lin Zhang
    Xiaoming Yu
    Zhongqiu Liu
    Qiang Wei
    Linlin Lu
    [J]. Oncogene, 2018, 37 : 1354 - 1368
  • [23] Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4
    Lv, Shidong
    Ji, Liyan
    Chen, Bin
    Liu, Shuqiang
    Lei, Chengyong
    Liu, Xi
    Qi, Xiaoxiao
    Wang, Ying
    Leung, Elaine Lai-Han
    Wang, Hongyi
    Zhang, Lin
    Yu, Xiaoming
    Liu, Zhongqiu
    Wei, Qiang
    Lu, Linlin
    [J]. ONCOGENE, 2018, 37 (10) : 1354 - 1368
  • [24] Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients
    Kayser, Sabine
    Feszler, Maximilian
    Krzykalla, Julia
    Schick, Matthias
    Kramer, Michael
    Benner, Axel
    Thol, Felicitas
    Platzbecker, Uwe
    Mueller-Tidow, Carsten
    Ho, Anthony D.
    Ehninger, Gerhard
    Heuser, Michael
    Schlenk, Richard F.
    Thiede, Christian
    Roellig, Christoph
    Kraemer, Alwin
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (06) : 544 - 552
  • [25] Clinical Impact of KMT2C and SPRY4 Expression Levels in Intensively Treated Younger Adult Acute Myeloid Leukemia Patients
    Kayser, Sabine
    Feszler, Maximilian
    Krzykalla, Julia
    Schick, Matthias
    Hielscher, Thomas
    Benner, Axel
    Kramer, Michael
    Thol, Felicitas
    Platzbecker, Uwe
    Ho, Anthony D.
    Ehninger, Gerhard
    Heuser, Michael
    Thiede, Christian
    Rollig, Christoph
    Kramer, Alwin
    [J]. BLOOD, 2016, 128 (22)
  • [26] Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas
    Chi, SG
    White, RWD
    Muenzer, JT
    Gumerlock, PH
    [J]. CLINICAL CANCER RESEARCH, 1997, 3 (10) : 1889 - 1897
  • [27] Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models
    Kabir, Farruk Mohammad Lutful
    DeInnocentes, Patricia
    Bird, Richard Curtis
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2015, 116 (12) : 2956 - 2969
  • [28] Down-regulated SOX4 Expression Suppresses Cell Proliferation, Metastasis and Induces Apoptosis in Xuanwei Female Lung Cancer Patients
    Zhou, Yongchun
    Wang, Xicai
    Huang, Yunchao
    Chen, Yan
    Zhao, Guangqiang
    Yao, Qian
    Jin, Congguo
    Huang, Youguang
    Liu, Xin
    Li, Guangjian
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2015, 116 (06) : 1007 - 1018
  • [29] Inhibition of KDM4C/c-Myc/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism
    Lin, Ching-Yu
    Wang, Bi-Juan
    Fu, Yu-Ke
    Huo, Chieh
    Wang, Ya-Pei
    Chen, Bo-Chih
    Liu, Wei-Yi
    Tseng, Jen-Chih
    Jiang, Shih Shen
    Sie, Zong-Lin
    Tsai, Kelvin K.
    Yuh, Chiou-Hwa
    Wang, Wen-Ching
    Kung, Hsing-Jien
    Chuu, Chih-Pin
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (03):
  • [30] Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer
    William F Benedict
    Seth P Lerner
    Jain Zhou
    Xiaohua Shen
    Hideo Tokunaga
    Bogdan Czerniak
    [J]. Oncogene, 1999, 18 : 1197 - 1203
12345